Tactogen
6 known investors
Find your way into Tactogen
36 people in our graph share verified history with the Tactogen team — schools, employers, funds. One of them is your warm intro.
Tom Drummondunlockedknows Matthew Baggott · together at Martini Media Inc. (overlapped)
×8knows the team · via University of Chicago
×3knows the team · via Martini Media Inc.
Tactogen develops patented new chemical entities, including benzofuran-based compositions, and conducts preclinical research and publishes data on these compounds. The company operates in the neuroscience and pharmaceutical drug development space.
Founders & leadership
MB
Matthew BaggottinCEOMatthew Baggott holds a PhD in neuroscience and has spent three decades in roles involving data science, preclinical pharmacology, clinical research, genomics, and drug development. He is CEO of Tactogen, which develops novel chemical compounds and conducts preclinical research in neuroscience and pharmaceutical development.
Investors · 6
In the news
Frequently asked questions
- What does Tactogen do?
- Tactogen develops patented new chemical entities, including benzofuran-based compositions, and conducts preclinical research and publishes data on these compounds. The company operates in the neuroscience and pharmaceutical drug development space.
- Who founded Tactogen?
- Tactogen was founded by Matthew Baggott.
- Who are Tactogen's investors?
- Tactogen's investors include Leafy Tunnel, Noetic, PsyMed Ventures, 10X Capital, Palo Santo, Wefunder.